Review



hek293t pad2 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    ATCC hek293t pad2 cells
    Hek293t Pad2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/pAD2/pmc05910237-254-0-46
    Average 90 stars, based on 10 article reviews
    hek293t pad2 cells - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Medications:

    Article Title: Use of Assistive Technology for Cognition Among People With Traumatic Brain Injury: A Survey Study
    Article Snippet: .. Difficulties and ATC Use in ADL Areas ADL Areas No. of Participants Who Had Difficulties (N = 29) No. of Participants Who Were Significantly Affecteda Total Number of ATC Used Types of ATC Devices Used in Each Areab Proportion of Portable Electronic ATCc Perform Multistep Tasks 19 15 (78.9%) 5 Smartphone (3) 60% Computer (1) Alarm/Timer (1) Keep Track of Appointments and Events 22 17 (77.3%) 29 Smartphone (16) 62.6% Computer (4) Smart Pad (2) Paper Tools (5) Alarm/Timer (2) Stay Focused on a Task 27 18 (66.7%) 4 Smartphone (1) 25% Computer (1) Paper Tools (1) Alarm/Timer (1) Keep Track of Taking Medications 17 11 (64.7%) 5 Smartphone (2) 40% Alarm/Timer (1) Pillbox(2) Remember Names and Faces 28 17 (60.7%) 5 Smartphone (1) 20% Computer (2) Paper Tools (2) Manage Emotion 22 13 (59.1%) 1 Smartphone (1) 100% Navigate Ways 17 9 (52.9%) 3 Smartphone (1) 100% GPS (2) Locate Items 26 9 (34.6%) 0 N/A N/A aThe percentage is based on the number of participants who reported difficulties in each ADL area. bDevice (n), n represents the frequency of the reported using ATC device. cSmartphone, computer, smart pad, and GPS are grouped into high-tech ATC category. ..

    Western Blot:

    Article Title: Deiminated proteins and extracellular vesicles as novel biomarkers in pinnipeds: Grey seal (Halichoerus gryptus) and harbour seal (Phoca vitulina).
    Article Snippet: .. Results 233 3.1 PAD and deiminated proteins in seal sera and serum-derived EVs 234 A PAD homologue was identified in the seal sera by Western blotting via cross reaction with human 235 PAD2 at an expected 70-75 kDa size (Fig 1A) and a human cancer cell line (glioblastoma multiforme 236 LN18, ATCC® CRL-2610TM, USA) was used as a positive control for PAD2 (Fig 1A.1) [22]. ..

    Positive Control:

    Article Title: Deiminated proteins and extracellular vesicles as novel biomarkers in pinnipeds: Grey seal (Halichoerus gryptus) and harbour seal (Phoca vitulina).
    Article Snippet: .. Results 233 3.1 PAD and deiminated proteins in seal sera and serum-derived EVs 234 A PAD homologue was identified in the seal sera by Western blotting via cross reaction with human 235 PAD2 at an expected 70-75 kDa size (Fig 1A) and a human cancer cell line (glioblastoma multiforme 236 LN18, ATCC® CRL-2610TM, USA) was used as a positive control for PAD2 (Fig 1A.1) [22]. ..

    Incubation:

    Article Title: Photochemical Control of Protein Arginine Deiminase (PAD) Activity
    Article Snippet: The membrane was then washed with PBST and imaged by Licor analysis. .. HEK293T/PAD2 cells were plated (2 × 10 4 cells/well) in a 96-well plate and were allowed to grow for 24 h. DMSO or various concentrations of inhibitor were added to the wells and incubated for 24 h. Cell viability was measured using the XTT reagent kit (ATCC) by recording the absorbance at 475 nm and 660 nm. .. An eight-point dose-response curve was fit to the following equation 3 using GraphPad Prism 7.03 to determine the EC 50 values for cell-growth inhibition, Y = Bottom + (Top-Bottom)/[1 + 10 ((logEC50-X)∗Hillslope) ], (3) where Top and Bottom are plateaus of the dose-response curve, X is the log of inhibitor-concentration, Hillslope is the slope factor or Hill slope.

    Article Title: Photochemical Control of Protein Arginine Deiminase (PAD) Activity.
    Article Snippet: .. HEK293T/PAD2 cells were plated (2 × 10 4 cells/well) in a 96-well plate and were allowed to grow for 24 h. DMSO or various concentrations of inhibitor were added to the wells and incubated for 24 h. Cell viability was measured using the XTT reagent kit (ATCC) by recording the absorbance at 475 nm and 660 nm. .. An eight-point Page 16 of 36 ACS Paragon Plus Environment ACS Chemical Biology 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 dose-response curve was fit to the following equation 3 using GraphPad Prism 7.03 to determine the EC50 values for cell-growth inhibition, Y = Bottom + (Top-Bottom) / [1 + 10 ((logEC50-X)*Hillslope) ] (3), where Top and Bottom are plateaus of the dose-response curve, X is the log of inhibitorconcentration, Hillslope is the slope factor or Hill slope.

    Transfection:

    Article Title: Proximity-dependent labeling of Cysteines
    Article Snippet: .. HEK293T cells (ATCC) were transfected with the pcDNA3.1-PAD2-NNMT, pcDNA3.1-NNMT-PAD2, pcDNA3.1-NNMTNLS, pcDNA3.1-PDK1-NNMT and pcDNA3.1-NNMTY20A constructs using Lipofectamine 2000 according to the manufacturer’s protocol. .. Stable transfection was established using Hygromycin (Corning) as a selection marker.

    Construct:

    Article Title: Proximity-dependent labeling of Cysteines
    Article Snippet: .. HEK293T cells (ATCC) were transfected with the pcDNA3.1-PAD2-NNMT, pcDNA3.1-NNMT-PAD2, pcDNA3.1-NNMTNLS, pcDNA3.1-PDK1-NNMT and pcDNA3.1-NNMTY20A constructs using Lipofectamine 2000 according to the manufacturer’s protocol. .. Stable transfection was established using Hygromycin (Corning) as a selection marker.

    other:

    Article Title: Biosynthesis of three N -acetylaminosugar-conjugated flavonoids using engineered Escherichia coli
    Article Snippet: pA-DHR-D2 , pACYCDuet + Pdeg and Preq from B. cereus ATCC 14579 + AtUGT78D2 , This study.

    Article Title: Abstracts
    Article Snippet: EXOSOME MEDIATED TRANSFER OF DNA METHYLTRANSFERASE MRNA DURING SEPSIS RESULTS IN METHYLATION EVENTS AND ALTERED GENE EXPRESSION Jon Wisler, Kanhaiya Singh, Chandan Sen, Adara McCarty, John Christman.. Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio, United States, Indiana University, Indianapolis, Indiana, United States, Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio, United States Introduction: Survivors of severe septic insults often develop persistent immunosuppression characterized by altered cytokine production and reduced phagocytosis.. Emerging research suggests epigenetic regulation is an important mechanism that can titrate the host immune response and may be responsible for some of these immunosuppressive changes.



    Similar Products

    91
    Proteintech antibodies against pad2
    Antibodies Against Pad2, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/PADI2+Fusion+Protein/pm42661280-85-18-21
    Average 91 stars, based on 1 article reviews
    antibodies against pad2 - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    94
    Proteintech anti pad2
    Anti Pad2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/PADI2+Antibody/pmc12966709-517-28-29
    Average 94 stars, based on 1 article reviews
    anti pad2 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    86
    Merck & Co pad2
    Pad2, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/pad2/bio_rxiv__64898__2026__02__12__705563-98-23-26
    Average 86 stars, based on 1 article reviews
    pad2 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress pad2
    Pad2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/AFM32a/pm41596642-163-11-21
    Average 94 stars, based on 1 article reviews
    pad2 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology abclonal technologies rabbit anti pad2
    (A) Confocal micrographs of primary myoblasts differentiated for 24 h and immunostained <t>with</t> <t>anti-PAD2</t> (red) and anti-PAD3 or anti-PAD4 (green) antibodies. Nuclei were counterstained with DAPI (blue). Scale bar, 5 μm. (B) Subcellular fractionation of primary myoblasts differentiated for 24 h showing whole-cell (WC), cytosolic (Cyt), and nuclear (Nuc.) fractions. Representative immunoblots (left) and corresponding quantification (right) of PAD2, PAD3, and PAD4 protein levels are shown. Lamin A/C and α-tubulin were used as purity controls for the nuclear and cytoplasmic fractions, respectively. 20 ug of each extract was loaded onto the gels. (C) Representative immunoblots (left) and quantification (right) of histone H3 citrullination marks (H3CitR2+R8+R17, H3CitR17, and H3CitR26) in proliferating (P or Prol), time 0 (0 h), or differentiating (24 h) primary myoblasts. (D-G) ChIP-qPCR analysis showing enrichment of H3CitR2+R8+R17 (D) , H3CitR26 (E) , H3CitR17 (G) and total H3 (H) at the Pax7 promoter and at regulatory sequences controlling the indicated myogenic genes in proliferating (Prol), time 0 (0 h), and differentiating (24 h) primary myoblasts. The IgH enhancer was included as a negative sequence control. Bar graphs represent mean ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. n.s., not significant.
    Abclonal Technologies Rabbit Anti Pad2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/PADI2+Rabbit+pAb/bio_rxiv__64898__2026__01__20__700682-204-5-5
    Average 94 stars, based on 1 article reviews
    abclonal technologies rabbit anti pad2 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    86
    Eurofins pad2
    (A) Confocal micrographs of primary myoblasts differentiated for 24 h and immunostained <t>with</t> <t>anti-PAD2</t> (red) and anti-PAD3 or anti-PAD4 (green) antibodies. Nuclei were counterstained with DAPI (blue). Scale bar, 5 μm. (B) Subcellular fractionation of primary myoblasts differentiated for 24 h showing whole-cell (WC), cytosolic (Cyt), and nuclear (Nuc.) fractions. Representative immunoblots (left) and corresponding quantification (right) of PAD2, PAD3, and PAD4 protein levels are shown. Lamin A/C and α-tubulin were used as purity controls for the nuclear and cytoplasmic fractions, respectively. 20 ug of each extract was loaded onto the gels. (C) Representative immunoblots (left) and quantification (right) of histone H3 citrullination marks (H3CitR2+R8+R17, H3CitR17, and H3CitR26) in proliferating (P or Prol), time 0 (0 h), or differentiating (24 h) primary myoblasts. (D-G) ChIP-qPCR analysis showing enrichment of H3CitR2+R8+R17 (D) , H3CitR26 (E) , H3CitR17 (G) and total H3 (H) at the Pax7 promoter and at regulatory sequences controlling the indicated myogenic genes in proliferating (Prol), time 0 (0 h), and differentiating (24 h) primary myoblasts. The IgH enhancer was included as a negative sequence control. Bar graphs represent mean ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. n.s., not significant.
    Pad2, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/pad2/pm41410813-91-17-22
    Average 86 stars, based on 1 article reviews
    pad2 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    94
    Proteintech pad2 antibody
    Generation of PAD2KO mice using the CRISPR-Cas9 systems and pathogenesis of TNBS-induced colitis in wild-type and PAD2KO mice. ( a ) The sequences produced for the generation of PAD2KO mice using the CRISPR-Cas9 systems, deficient in 61-bp on exon2 of the genomic <t>PAD2</t> DNA. ( b ) PAD2 mRNA level was determined in intraperitoneal macrophages by qRT-PCR normalized to TBP. Data were presented as the means ± S.E.M. (n = 8). ****P < 0.0001 vs. wild-type (WT) mice. ( c ) PAD2 expression was determined in intraperitoneal macrophages by western blotting normalized to β-actin expression. Data are presented as the means ± S.E.M. (n = 3). ***P < 0.001 vs. WT mice. ( d ) Body weight was measured daily in untreated-, vehicle (30% ethanol)-, or TNBS-injected WT and PAD2KO mice. On day 3, colon length was measured ( e ), representative images were obtained ( f ), and macroscopic analyses of the injured area were carried out using Image J ( g ). Scale bars are 10 mm. Histological changes were observed following H&E staining ( h ). ( i ) MPO activity was determined in those mice. Data are presented as the means ± S.E.M. (n = 8–9). #### P < 0.0001 vs. vehicle-injected mice (WT EtOH), and ****P < 0.0001, ***P < 0.001, *P < 0.05 vs. TNBS-injected mice (WT TNBS).
    Pad2 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad2/PADI2+Antibody/pmc12627834-76-6-9
    Average 94 stars, based on 1 article reviews
    pad2 antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Confocal micrographs of primary myoblasts differentiated for 24 h and immunostained with anti-PAD2 (red) and anti-PAD3 or anti-PAD4 (green) antibodies. Nuclei were counterstained with DAPI (blue). Scale bar, 5 μm. (B) Subcellular fractionation of primary myoblasts differentiated for 24 h showing whole-cell (WC), cytosolic (Cyt), and nuclear (Nuc.) fractions. Representative immunoblots (left) and corresponding quantification (right) of PAD2, PAD3, and PAD4 protein levels are shown. Lamin A/C and α-tubulin were used as purity controls for the nuclear and cytoplasmic fractions, respectively. 20 ug of each extract was loaded onto the gels. (C) Representative immunoblots (left) and quantification (right) of histone H3 citrullination marks (H3CitR2+R8+R17, H3CitR17, and H3CitR26) in proliferating (P or Prol), time 0 (0 h), or differentiating (24 h) primary myoblasts. (D-G) ChIP-qPCR analysis showing enrichment of H3CitR2+R8+R17 (D) , H3CitR26 (E) , H3CitR17 (G) and total H3 (H) at the Pax7 promoter and at regulatory sequences controlling the indicated myogenic genes in proliferating (Prol), time 0 (0 h), and differentiating (24 h) primary myoblasts. The IgH enhancer was included as a negative sequence control. Bar graphs represent mean ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. n.s., not significant.

    Journal: bioRxiv

    Article Title: Reciprocal regulation between the protein arginine deiminases and mSWI/SNF chromatin remodelers controls skeletal muscle differentiation and regeneration

    doi: 10.64898/2026.01.20.700682

    Figure Lengend Snippet: (A) Confocal micrographs of primary myoblasts differentiated for 24 h and immunostained with anti-PAD2 (red) and anti-PAD3 or anti-PAD4 (green) antibodies. Nuclei were counterstained with DAPI (blue). Scale bar, 5 μm. (B) Subcellular fractionation of primary myoblasts differentiated for 24 h showing whole-cell (WC), cytosolic (Cyt), and nuclear (Nuc.) fractions. Representative immunoblots (left) and corresponding quantification (right) of PAD2, PAD3, and PAD4 protein levels are shown. Lamin A/C and α-tubulin were used as purity controls for the nuclear and cytoplasmic fractions, respectively. 20 ug of each extract was loaded onto the gels. (C) Representative immunoblots (left) and quantification (right) of histone H3 citrullination marks (H3CitR2+R8+R17, H3CitR17, and H3CitR26) in proliferating (P or Prol), time 0 (0 h), or differentiating (24 h) primary myoblasts. (D-G) ChIP-qPCR analysis showing enrichment of H3CitR2+R8+R17 (D) , H3CitR26 (E) , H3CitR17 (G) and total H3 (H) at the Pax7 promoter and at regulatory sequences controlling the indicated myogenic genes in proliferating (Prol), time 0 (0 h), and differentiating (24 h) primary myoblasts. The IgH enhancer was included as a negative sequence control. Bar graphs represent mean ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. n.s., not significant.

    Article Snippet: Rabbit anti-BAF250A (A18650) was from Abclonal Technologies Rabbit anti-PAD2 (E3P8Z; #97647), anti-vinculin (E1E9V; #13901), anti-Histone H3 (#9715), Histone H3Cit R17 (E4O3F; #97272), and anti-DPF2 (E7N8J; #71642) were from Cell Signaling Technologies.

    Techniques: Fractionation, Western Blot, ChIP-qPCR, Sequencing, Control

    Generation of PAD2KO mice using the CRISPR-Cas9 systems and pathogenesis of TNBS-induced colitis in wild-type and PAD2KO mice. ( a ) The sequences produced for the generation of PAD2KO mice using the CRISPR-Cas9 systems, deficient in 61-bp on exon2 of the genomic PAD2 DNA. ( b ) PAD2 mRNA level was determined in intraperitoneal macrophages by qRT-PCR normalized to TBP. Data were presented as the means ± S.E.M. (n = 8). ****P < 0.0001 vs. wild-type (WT) mice. ( c ) PAD2 expression was determined in intraperitoneal macrophages by western blotting normalized to β-actin expression. Data are presented as the means ± S.E.M. (n = 3). ***P < 0.001 vs. WT mice. ( d ) Body weight was measured daily in untreated-, vehicle (30% ethanol)-, or TNBS-injected WT and PAD2KO mice. On day 3, colon length was measured ( e ), representative images were obtained ( f ), and macroscopic analyses of the injured area were carried out using Image J ( g ). Scale bars are 10 mm. Histological changes were observed following H&E staining ( h ). ( i ) MPO activity was determined in those mice. Data are presented as the means ± S.E.M. (n = 8–9). #### P < 0.0001 vs. vehicle-injected mice (WT EtOH), and ****P < 0.0001, ***P < 0.001, *P < 0.05 vs. TNBS-injected mice (WT TNBS).

    Journal: Scientific Reports

    Article Title: Peptidylarginine deiminase 2 contributes to pathogenesis in trinitrobenzenesulfonic acid-induced colitis through macrophage extracellular trap-independent pathways

    doi: 10.1038/s41598-025-24221-2

    Figure Lengend Snippet: Generation of PAD2KO mice using the CRISPR-Cas9 systems and pathogenesis of TNBS-induced colitis in wild-type and PAD2KO mice. ( a ) The sequences produced for the generation of PAD2KO mice using the CRISPR-Cas9 systems, deficient in 61-bp on exon2 of the genomic PAD2 DNA. ( b ) PAD2 mRNA level was determined in intraperitoneal macrophages by qRT-PCR normalized to TBP. Data were presented as the means ± S.E.M. (n = 8). ****P < 0.0001 vs. wild-type (WT) mice. ( c ) PAD2 expression was determined in intraperitoneal macrophages by western blotting normalized to β-actin expression. Data are presented as the means ± S.E.M. (n = 3). ***P < 0.001 vs. WT mice. ( d ) Body weight was measured daily in untreated-, vehicle (30% ethanol)-, or TNBS-injected WT and PAD2KO mice. On day 3, colon length was measured ( e ), representative images were obtained ( f ), and macroscopic analyses of the injured area were carried out using Image J ( g ). Scale bars are 10 mm. Histological changes were observed following H&E staining ( h ). ( i ) MPO activity was determined in those mice. Data are presented as the means ± S.E.M. (n = 8–9). #### P < 0.0001 vs. vehicle-injected mice (WT EtOH), and ****P < 0.0001, ***P < 0.001, *P < 0.05 vs. TNBS-injected mice (WT TNBS).

    Article Snippet: The membranes were then incubated with PAD2 antibody (1:500) (Proteintech, 12110-1-AP) and β-actin antibody (1:2000) (CST, #4970).

    Techniques: CRISPR, Produced, Quantitative RT-PCR, Expressing, Western Blot, Injection, Staining, Activity Assay

    Expression of inflammatory cytokines, chemokines, and PAD2 in PAD2KO mice. ( a ) TNFα, ( b ) IL-1β, ( c ) IL-12, ( d ) IL-23, ( e ) IFNγ, ( f ) CXCL2, and ( g ) PAD2 mRNA expression were determined using qRT-PCR in colon tissues of vehicle (30% ethanol)-, or TNBS-injected WT and PAD2KO mice on day 3, and mRNA levels were normalized to TBP. Data are presented as the means ± S.E.M. (n = 8–10). #### P < 0.0001, ### P < 0.001, ## P < 0.01 vs. vehicle-injected mice (WT EtOH), and ****P < 0.0001, *P < 0.05 vs. TNBS-injected mice (WT TNBS).

    Journal: Scientific Reports

    Article Title: Peptidylarginine deiminase 2 contributes to pathogenesis in trinitrobenzenesulfonic acid-induced colitis through macrophage extracellular trap-independent pathways

    doi: 10.1038/s41598-025-24221-2

    Figure Lengend Snippet: Expression of inflammatory cytokines, chemokines, and PAD2 in PAD2KO mice. ( a ) TNFα, ( b ) IL-1β, ( c ) IL-12, ( d ) IL-23, ( e ) IFNγ, ( f ) CXCL2, and ( g ) PAD2 mRNA expression were determined using qRT-PCR in colon tissues of vehicle (30% ethanol)-, or TNBS-injected WT and PAD2KO mice on day 3, and mRNA levels were normalized to TBP. Data are presented as the means ± S.E.M. (n = 8–10). #### P < 0.0001, ### P < 0.001, ## P < 0.01 vs. vehicle-injected mice (WT EtOH), and ****P < 0.0001, *P < 0.05 vs. TNBS-injected mice (WT TNBS).

    Article Snippet: The membranes were then incubated with PAD2 antibody (1:500) (Proteintech, 12110-1-AP) and β-actin antibody (1:2000) (CST, #4970).

    Techniques: Expressing, Quantitative RT-PCR, Injection